Gene News and Research

Latest Gene News and Research

Glioblastoma's molecular flexibility helps resist nearly all treatment efforts

Glioblastoma, the most common and lethal form of brain cancer and the disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even when attacked simultaneously on several fronts. One explanation can be found in the tumor cells' unexpected flexibility, discovered researchers at the Salk Institute for Biological Studies.

25 Jan 2011

m2m, HP collaborate to prevent mother-to-child HIV transmission in Africa

Today at the Digital Life Design conference, HP and mothers2mothers (m2m), a South Africa-based nongovernmental organization, announced a new collaboration that will use the power of technology to help prevent the transmission of HIV from HIV-positive pregnant mothers in Africa to their children.

25 Jan 2011

Cellectis to launch gene specific TAL nucleases

Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, has today announced that it will launch gene specific TAL nucleases on February 28, 2011.

25 Jan 2011

World's largest sterile compounding center for oncology patients

Health Robotics today announced the official opening and live operation of the largest Sterile Compounding Center for Oncology patients in the world. Akdeniz University Hospital in Antalya (Turkey) compounds 90% of its 80.000 annual chemotherapy intravenous doses with 4 CytoCare robots and related Health Robotics' technology, or an average of 325 patient doses per 6-hour work cycle.

25 Jan 2011

Human model of rare genetic disease reveals new clues to aging process

Scientists from A*STAR's Institute of Medical Biology (IMB) in Singapore and the University of Hong Kong's Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide. This model has allowed them to make new discoveries concerning the mechanism by which progeria works.

25 Jan 2011

University of California study may shed light on human ability to adapt hypoxia

In an important study that may shed light on human ability to adapt to hypoxia, or inadequate levels of oxygen, researchers at the University of California, San Diego School of Medicine have proven that the genome of flies exposed to long-term hypoxia are changed to permanently affect gene expression.

24 Jan 2011

Blocking rogue gene may stop cancer spread: Study

In a new breakthrough British scientists have discovered a “rogue gene” which helps cancer spread around the body and add that this could mean specific therapy, if developed against the gene, could stop cancer spread.

24 Jan 2011

NYSE Amex accepts Cardium's exchange listing compliance plan

Cardium Therapeutics reported that its exchange listing compliance plan submitted on December 2, 2010 has been accepted by the NYSE Amex LLC.

24 Jan 2011

ArQule's ARQ 197 Phase 1 clinical trial results in colorectal cancer presented at ASCO 2011

ArQule, Inc. today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule.

24 Jan 2011

Senesco files SNS01-T IND for treatment of multiple myeloma

Senesco Technologies, Inc. today announced that the Company has filed an Investigational New Drug application with the U.S. Food and Drug Administration for Senesco's lead drug candidate SNS01-T for treatment of multiple myeloma.

24 Jan 2011

Rogue gene blocked by right drugs could stop cancer

Scientists at the University of East Anglia (UEA) have discovered a rogue gene which - if blocked by the right drugs - could stop cancer in its tracks.

24 Jan 2011

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have made a breakthrough in understanding the mechanisms behind the most severe form of hereditary emphysema and how protein treatments can improve the condition. The findings of this study may also lead to new treatments for patients with smoker's emphysema.

24 Jan 2011

Exiqon launches new Hi-Power microRNA labeling kits

Exiqon, a leading supplier of high-value gene expression analysis products, today announced the launch of the 3rd generation of miRCURY LNA microRNA Labeling Kit called Hi-Power for labeling of microRNAs for downstream hybridization to microRNA arrays.

24 Jan 2011

Nutrient 'biomarkers' may help assess nutrient status of elderly people at risk for dementia

Research is trying to determine whether Alzheimer's disease might be slowed or prevented with nutritional approaches, but a new study suggests those efforts could be improved by use of nutrient "biomarkers" to objectively assess the nutrient status of elderly people at risk for dementia.

24 Jan 2011

Functional tests are necessary to understand human disease despite genetic sequencing

Despite what you might have heard, genetic sequencing alone is not enough to understand human disease. Researchers at Duke University Medical Center have shown that functional tests are absolutely necessary to understand the biological relevance of the results of sequencing studies as they relate to disease, using a suite of diseases known as the ciliopathies which can cause patients to have many different traits.

24 Jan 2011

Mutation of microRNA miR-96 causes deafness

New research from the University of Sheffield has revealed that the molecular mechanism underlying deafness is caused by a mutation of a specific microRNA called miR-96. The discovery could provide the basis for treating progressive hearing loss and deafness.

21 Jan 2011

Everist Genomics reports positive results from OncoDefender-CRC assay external validation study

Everist Genomics, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced the positive results of the first external validation study of its OncoDefender-CRC colorectal cancer recurrence test. The study is being conducted by Mayo Validation Support Services, and is being coordinated with investigators and resources from all three Mayo Clinic sites.

21 Jan 2011

Researchers reveal how genetic mutation contributes to cancer development

Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.

21 Jan 2011

Additional data from HyperAcute Pancreas cancer immunotherapy Phase 2 trial to be presented at ASCO 2011

NewLink Genetics Corporation today announced that additional data from its Phase 2 clinical trial of the company's investigational HyperAcute® Pancreas cancer immunotherapy will be presented during a poster session at the American Society of Clinical Oncology 2011 Gastrointestinal Cancers Symposium in San Francisco, California.

21 Jan 2011

Acetylation complex fits like a halo over a histone

To understand the emerging science of epigenetics-a field that describes how genes may be regulated without altering the underlying DNA itself-scientists are deciphering the many ways in which enzymes act on the proteins surrounding DNA within cells.

21 Jan 2011

Gene News and Research

Latest Gene News and Research

Glioblastoma's molecular flexibility helps resist nearly all treatment efforts

m2m, HP collaborate to prevent mother-to-child HIV transmission in Africa

Cellectis to launch gene specific TAL nucleases

World's largest sterile compounding center for oncology patients

Human model of rare genetic disease reveals new clues to aging process

University of California study may shed light on human ability to adapt hypoxia

Blocking rogue gene may stop cancer spread: Study

NYSE Amex accepts Cardium's exchange listing compliance plan

ArQule's ARQ 197 Phase 1 clinical trial results in colorectal cancer presented at ASCO 2011

Senesco files SNS01-T IND for treatment of multiple myeloma

Rogue gene blocked by right drugs could stop cancer

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Exiqon launches new Hi-Power microRNA labeling kits

Nutrient 'biomarkers' may help assess nutrient status of elderly people at risk for dementia

Functional tests are necessary to understand human disease despite genetic sequencing

Mutation of microRNA miR-96 causes deafness

Everist Genomics reports positive results from OncoDefender-CRC assay external validation study

Researchers reveal how genetic mutation contributes to cancer development

Additional data from HyperAcute Pancreas cancer immunotherapy Phase 2 trial to be presented at ASCO 2011

Acetylation complex fits like a halo over a histone

eBook: Using iPSCs models for human disease research and drug discovery eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy